News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mallinckrodt Inc. Reports Financial Results for Third Fiscal Quarter 2013


8/9/2013 7:03:22 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuticals and global medical imaging business, today reported results for the third quarter of fiscal 2013, ended June 28, 2013.

Net sales were $570.0 million for the third fiscal quarter of 2013, an increase of 10.4%, compared with $516.3 million reported in the third quarter of fiscal 2012.

Hey, check out all the engineering jobs. Post your resume today!

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES